Indeed, there are already several studies exploring disease-specific therapies in Drosophila. For instance, a recent study investigated the effectiveness of several ASMs in a Drosophila model of KCNT1-epilepsy (Hussain et al., 2024). This evidence concerns the gene KCNT1 and epilepsy.